CRL · 10-Q · 2026Q2 · Full report

Regulatory Risk

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 37 · Surprise 42

The company continues to incur costs related to investigations by the U.S. government into its non-human-primate (NHP) supply chain. Third-party legal costs associated with those investigations declined in the first half of 2026 compared with the prior-year period, but the investigation remains a regulatory matter affecting the DSA business. Charles River’s acquisition of the Cambodian NHP supplier for $507.3 million further expands its vertically integrated NHP operations subject to this regulatory environment.

Key facts

• Company notes lower third-party legal costs associated with investigations by the U.S. government into the NHP supply chain contributed to increased DSA operating income. source